The latest report by IMARC Group, titled “Syringes Market Report by Product (General Syringes, Specialized Syringes, and Others), Material (Glass Syringes, Polymer Syringes), Usage (Disposable Syringes, Reusable Syringes), Distribution Channel (Offline, Online), End User (Hospitals and Clinics, Diagnostic Centers, Speciality Centers, and Others), and Region 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on the syringes market share.

How big is the syringes market?

The global syringes market size reached US$ 19.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 37.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.29% during 2024-2032.

Factors Driving Growth in the Syringes Industry:

• Technological Advancements in Syringe Design and Manufacturing: The syringes industry has witnessed a significant transformation in design and manufacturing processes with cutting-edge technological advancements. Safety-engineered syringes have revolutionized safety, precision, and usability by incorporating features to prevent needlestick injuries and bloodborne pathogen transmission. These safety mechanisms, including retractable needles and shields, are pivotal in healthcare settings, safeguarding healthcare workers and patients. Moreover, materials science innovations have led to the production of disposable syringes from durable, lightweight plastics, enhancing performance and compatibility with a range of medications, including biologics and vaccines.
• Surge in Chronic Diseases and Vaccination Programs: The escalating incidence of chronic diseases like diabetes, cancer, and cardiovascular ailments, coupled with global immunization initiatives, propels the demand for syringes. Syringes play a vital role in medication administration for disease management and prevention, from insulin for diabetes to chemotherapy drugs for cancer treatment and vaccines for infectious diseases. With aging populations and lifestyle-related health issues on the rise, the need for syringes for disease control is anticipated to increase. Governments and healthcare bodies promote vaccination programs against diseases like influenza, measles, and COVID-19, leading to heightened requirements for syringes for widespread immunization campaigns and routine vaccination schedules.
• Growing Healthcare Investments and Infrastructure Enhancements: The syringes market benefits from rapid urbanization, economic progress, and augmented healthcare spending in emerging markets, fueling the development and modernization of healthcare infrastructure. This involves equipping hospitals and clinics with state-of-the-art medical supplies, including syringes. As healthcare investments rise to enhance access and quality, there is a corresponding surge in demand for medical devices like syringes. Advancements in healthcare delivery models, such as telemedicine and home healthcare services, require reliable and user-friendly devices like syringes for convenient patient care beyond traditional settings. Additionally, heightened awareness of infection control and patient safety drives healthcare providers to prioritize the use of sterile, high-quality syringes manufactured according to stringent regulatory standards, boosting market growth as facilities upgrade their syringe inventory to meet safety and quality norms.

For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/syringes-market/requestsample

Competitive Landscape:

The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.

• Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• Cardinal Health Inc.
• Gerresheimer AG
• Hindustan Syringes & Medical Devices Ltd.
• Nipro Corporation
• Pfizer Inc.
• Retractable Technologies Inc.
• Schott AG
• Smiths Group plc
• Terumo Corporation
• Thomas Scientific LLC.

Syringes Market Report Segmentation:

By Product:

• General Syringes
• Specialized Syringes
  • Insulin Syringes
  • Tuberculin Syringes
  • Allergy Syringes
• Others

Based on the product, the market has been divided into general syringes, specialized syringes (insulin syringes, tuberculin syringes, and allergy syringes), and others.

By Material:

• Glass Syringes
• Polymer Syringes

On the basis of the material, the market has been segmented into glass syringes and polymer syringes.

By Usage:

• Disposable Syringes
  • Conventional Syringes
  • Safety Syringes
  • Prefilled Syringes
• Reusable Syringes

Based on the usage, the market has been segregated into disposable syringes (conventional syringes, safety syringes, prefilled syringes), and reusable syringes.

By Distribution Channel:

• Offline
• Online

On the basis of the distribution channel, the market has been categorized into online and offline.

By End User:

• Hospitals and Clinics
• Diagnostic Centers
• Speciality Centers
• Others

Based on the end user, the market has been divided into hospitals and clinics, diagnostic centers, specialty centers, and others.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Region-wise, the market has been classified into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.

Global Syringes Market Trends:

The trend toward self-administration of medications and the preference for home healthcare solutions drive the demand for syringes designed for safe and easy patient use outside clinical environments. Patients managing chronic conditions, from rheumatoid arthritis to multiple sclerosis, benefit from self-administration for convenient at-home treatment management. Moreover, emphasis on preventive healthcare strategies to curb infectious diseases and enhance public health outcomes leads to increased investments in immunization campaigns targeting children and adults, aiming to combat vaccine-preventable diseases such as polio, hepatitis, and HPV.

Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=5665&flag=C

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163